Switzerland
Medical device market intelligence for Switzerland. Regulatory changes, competitor moves, and procurement trends.
Recent signals
The Anecova Intra Uterine Culture Device study was withdrawn, impacting post-market surveillance efforts.
The Thunderbeat vessel sealing device is evaluated for safety and blood loss in laparoscopic surgeries.
Topcon CT-1® shows higher intraocular pressure than Goldmann tonometry in a study with 58 healthy eyes.
The ReHandyBot study is recruiting to evaluate unsupervised hand rehabilitation therapy for stroke patients at home.
Orchid Orthopedics Switzerland GmbH has registered product code OVE with the FDA.
A clinical trial is recruiting to evaluate the Smart Needle Monitoring System for safe injection pressure during PNB.
A completed study compares a new hearing aid's performance to an existing Bernafon model under various conditions.
Tempur Sealy DACH GmbH registered the Sealy Evolution 80x200x25 as a Class I medical device in EUDAMED.
Jabil Inc. has registered a medical device under product code HTJ with the FDA.
The study compares Amplatzer Amulet and Watchman devices for left atrial appendage closure in NVAF patients.
Aktiia SA is recruiting for a study to validate its optical blood pressure monitoring device against traditional methods.
Abbott's NxTekTM malaria RDTs are under evaluation for WHO Prequalification to improve malaria detection.
A new indirect calorimetry device is being developed to improve energy expenditure measurement in critically ill patients.
A study evaluates the efficacy of the Prismalung+ device for treating hypercapnic respiratory failure.
A study analyzes first-attempt endotracheal intubation success rates in Zug Rescue Service using various airway devices.
A completed study evaluated the efficacy of Apaisant Serum for pain relief in ingrown toenails.
Andago V2.0 is a new device for gait rehabilitation in stroke patients, focusing on usability and acceptance.
A completed trial shows a mandibular advancement device (MAD) may reduce sleep apnea after general anesthesia.
The B.Well BP25 study will validate a non-invasive sphygmomanometer per ISO standards, not yet recruiting volunteers.
Powered bone marrow biopsy devices improve biopsy quality over manual systems, as shown in a completed study.